Directors in the pharmaceutical industry are set to benefit from a new collaboration between the Institute of Directors (IoD) and the Association of the British Pharmaceutical Industry (ABPI). The IoD's Company Direction programme is, for the first time, being tailored to the needs of the pharmaceutical industry.
The programme covers all aspects of corporate governance and directors' responsibilities and focuses on strategies to improve business performance. Applicants who successfully pass the examination will be awarded the IoD/ABPI Diploma in Company Direction.
ABPI President Vincent Lawton said: "This diploma marks the way forward in setting the highest professional standards in an industry that already prides itself in the quality of its management. The programme offers directors a unique and valuable opportunity to develop the skills and knowledge relevant to their role. I am sure that leaders who successfully complete the diploma will be making a wise and rewarding investment in their future."
The Director-General of the IoD George Cox said "Pressure grows continuously for a high level of professionalism in the boardroom; competition, ever-greater public scrutiny, rising standards of governance and greater demand by shareholders all contribute towards this. The IoD's Company Direction Programme is a major contributor towards equipping directors in this field."
The programme is structured as a series of eight workshop modules, ranging from one to three days, to be taken over two years. Participants will gain new skills and knowledge, a wider understanding of corporate purpose and create a peer level network to help them fulfil their roles more effectively and confidently.
Subjects covered include finance, law and marketing specifically in the context of the pharmaceutical industry. Successful completion of the diploma can lead on to the IoD's professional qualification, Chartered Director.
For further information, please contact: ABPI Press Office 020 7747 1410